BioCentury
ARTICLE | Company News

AngioGenex, Albert Einstein College of Medicine deal

September 9, 2002 7:00 AM UTC

The medical school granted AngioGenex exclusive worldwide rights to its Id2 gene IP, for use in developing diagnostics and therapeutics for childhood cancers of the nervous system. ...